Bristol-Myers Squibb
BMY
BMY
1,640 hedge funds and large institutions have $73.8B invested in Bristol-Myers Squibb in 2017 Q3 according to their latest regulatory filings, with 128 funds opening new positions, 611 increasing their positions, 650 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 1,592 → 1,640 (+48)
0.94% more ownership
Funds ownership: 69.57% → 70.51% (+0.94%)
6% less repeat investments, than reductions
Existing positions increased: 611 | Existing positions reduced: 650
Holders
1,640
Holding in Top 10
58
Calls
$1.96B
Puts
$1.56B
Top Buyers
| 1 | +$336M | |
| 2 | +$238M | |
| 3 | +$232M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$199M |
| 5 |
Parnassus Investments
San Francisco,
California
|
+$172M |
Top Sellers
| 1 | -$362M | |
| 2 | -$216M | |
| 3 | -$176M | |
| 4 |
Renaissance Technologies
New York
|
-$168M |
| 5 |
State Street
Boston,
Massachusetts
|
-$138M |